Home / People / Borys Danevych
Portrait of Borys Danevych

Borys Danevych

Partner
Life Sciences & Healthcare

Contact
CMS Cameron McKenna Nabarro Olswang
6th Floor, 38 Volodymyrska Street
01054 Kyiv
Ukraine
Languages English, Russian, Ukrainian

Borys Danevych is a Partner and Head of Life Sciences & Healthcare practices at CMS Cameron McKenna Nabarro Olswang Ukraine with more than 15-years of experience working with international pharmaceutical, biotech, research and development, and medical devices companies, as well as healthcare services and health technology organisations. He regularly advises clients on regulatory, anti-counterfeiting, compliance in life sciences, pharmaceutical competition and IP, policy dialogue projects and regulatory disputes. Borys also counsels clients on employment and personal data protection issues, investor-state disputes, and white-collar criminal investigations.

As a leading life sciences lawyer in Ukraine, Borys is widely recognised for his work in the sector. He is ranked in Chambers Europe as a leading IP practitioner, with a focus on life sciences and pharmaceuticals, and enjoys further mentions in Legal 500 for his white-collar, competition and IP advice, as well as life-sciences-related dispute resolution.

more less

Memberships & Roles

2018 - Member of the Ethics Committee of the Ukraine Network of Integrity and Compliance

2009 - Co-Chair of the Healthcare Committee, American Chamber of Commerce in Ukraine

2006 - Advocate (Attorney-at-Law) Certificate, Kyiv City Qualification Disciplinary Bar Commission, Ukraine

more less

Education

2006 - Master's in Law Diploma (with Honours), National University of Kyiv-Mohyla Academy

more less
12/10/2020
CMS strengthens glob­al life sci­ences of­fer­ing with four-strong law­yer hire...
In­ter­na­tion­al law firm CMS is pleased to an­nounce that Borys Danevych will be join­ing the firm as a part­ner and Head of Life Sci­ences at CMS Camer­on McK­enna Nabarro Olswang in Ky­iv from 1 Novem­ber 2020...

Feed

06/12/2021
In­vest­ing and Do­ing Busi­ness in Ukraine 2021 Guide
A guide cov­er­ing over 25 sec­tors and in­dus­tries
17/09/2021
Vac­cine com­pens­a­tion re­gimes in Ukraine
1. Are COV­ID-19 vac­cin­a­tions ob­lig­at­ory in your jur­is­dic­tion? Are you ex­pect­ing any le­gis­lat­ive changes to en­able man­dat­ory vac­cines for all or cer­tain people (e.g. health­care pro­fes­sion­als, pub­lic ser­vants...
Comparable
16/09/2021
Ukraine par­lia­ment launches his­tor­ic re­vi­sion of phar­ma­ceut­ic­al le­gis­la­tion
On 9 Septem­ber 2021, the Ukrain­i­an par­lia­ment sup­por­ted in the first read­ing a re­vi­sion of its le­gis­la­tion on medi­cines, ini­ti­at­ing a two-week peri­od for sub­mit­ting amend­ments to the ba­sic ver­sion. Sev­er­al...
14/09/2021
Le­gis­lat­ive frame­works to com­bat il­li­cit trade in med­ic­al products in Ukraine
1. What le­gis­lat­ive frame­work is there to com­bat il­li­cit trad­ing and oth­er il­leg­al activ­it­ies in coun­ter­feited/fals­i­fied/di­ver­ted medi­cines in your jur­is­dic­tion? The Ukrain­i­an leg­al frame­work aimed at...
Comparable
09/08/2021
Ukraine changes qual­ity con­trol rules for im­por­ted medi­cines
On 21 Ju­ly 2021 the Cab­in­et of Min­is­ters of Ukraine amended its Res­ol­u­tion No. 902 On State Qual­ity Con­trol of Im­por­ted Medi­cines. The amend­ments took ef­fect on 27 Ju­ly 2021. The key points con­tained...
13/05/2021
Can­nabis law and le­gis­la­tion in Ukraine
Med­ic­al use Ex­cept for the lim­ited use of cer­tain can­nabis-based psy­cho­act­ive sub­stances (Nab­i­lone, Nabix­imols and Dronabin­ol) (the “Al­lowed Sub­stances”) for med­ic­al pur­poses, the med­ic­al use of...
05/05/2021
Com­pet­i­tion law en­force­ment in the phar­ma­ceut­ic­als sec­tor in Ukraine
1. Is there any spe­cif­ic reg­u­lat­ory frame­work that deals with com­pet­i­tion reg­u­la­tion in the phar­ma­ceut­ic­al sec­tor in your coun­try? The phar­ma­ceut­ic­al sec­tor is covered by gen­er­al com­pet­i­tion reg­u­la­tions...
Comparable
31/03/2021
Ukraine re­leases COV­ID-19 vac­cine and bio­phar­ma­ceut­ic­al man­u­fac­tur­ers from...
On 19 March 2021, the Ukrain­i­an par­lia­ment amended the Law of Ukraine “On medi­cines” in part on the emer­gency-use au­thor­isa­tion for the COV­ID-19 vac­cines and bio­lo­gics. When au­thor­ised by the Cab­in­et...
19/03/2021
Phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising in...
1. Which laws are ap­plic­able re­gard­ing ad­vert­ising of medi­cines and med­ic­al devices? Art­icle 21 of the Law on Ad­vert­ising No. 270/96-ВР dated 3 Ju­ly 1996 (as amended) (the “Law on Ad­vert­ising”)...
11/02/2021
Anti-coun­ter­feit­ing and Il­li­cit Trade
Des­pite COV­ID-19 vac­cines be­ing only a few months old, we are already see­ing the con­fis­ca­tion of coun­ter­feit vac­cines and the il­li­cit trade of genu­ine vac­cines. For those in the life sci­ences and health...
14/12/2020
Di­git­al health apps and telemedi­cine in Ukraine
Di­git­al Health Apps/Soft­ware 1. How is the soft­ware with­in di­git­al health apps clas­si­fied in your jur­is­dic­tion, and what reg­u­la­tion(s) ap­ply? 1.1 Is it con­sidered a “med­ic­al device” or a “product”...
Comparable